Table 1

Factors associated with ever being tested for GC/CT

N (%)Univariablep ValueMultivariable
HR (95% CI) of ever-being testedAHR (95% CI) of ever-being tested
Time period of enrollment
1999 to June 2003819 (73.8)1.00 (ref)1.00 (ref)
July 2003–2007291 (26.2)2.65 (2.11 to 3.33)<0.0012.70 (2.15 to 3.40)
Mean visits/year
<4389 (35.1)1.00 (ref)1.00 (ref)
≥4721 (65.0)1.51 (1.23 to 1.84)<0.0011.55 (1.27 to 1.91)
Age, y
Median (IQR)41 (35-46)
18–29105 (9.5)2.01 (1.36 to 2.97)<0.0012.42 (1.63 to 3.59)
30–39372 (33.5)1.13 (0.80 to 1.57)0.491.39 (0.99 to 1.95)
40–49465 (41.9)1.37 (0.99 to 1.90)0.051.53 (1.11 to 2.12)
≥50168 (15.1)1.00 (ref)1.00 (ref)
Race/ethnicity
African-American861 (77.6)1.31 (1.02 to 1.67)0.031.31 (1.03 to 1.67)
White212 (19.1)1.00 (ref)1.00 (ref)
Other37 (3.3)**
HIV risk factor HET
Yes473 (42.6)1.09 (0.90 to 1.32)0.37
No637 (57.4)1.00 (ref)
HIV risk factor IDU
Yes453 (40.8)0.93 (0.76 to 1.13)0.45
No657 (59.2)1.00 (ref)
HIV risk factor MSM
Yes368 (33.2)1.11 (0.91 to 1.36)0.31
No742 (66.9)1.00 (ref)
Enrollment CD4 count
<200 cells/mm3476 (42.9)1.00 (ref)
≥200634 (57.1)0.96 (0.79 to 1.16)0.66
Enrollment HIV RNA
<1000 copies/ml256 (23.1)1.00 (Ref)
1000–99 999528 (47.6)1.01 (0.79 to 1.30)0.91
≥100 000326 (29.4)1.13 (0.87 to 1.48)0.36
Initiated HAART
Ever927 (83.5)1.08 (0.82 to 1.43)0.58
Never183 (16.5)1.00 (ref)
  • Values expressed as number (per cent) unless otherwise noted. Enrollment HIV RNA was missing for nine men.

  • * The racial category ‘other’ was combined with ‘white’ for univariable and multivariable Cox regression analysis.

  • Reporting more than one HIV risk factor was allowed.

  • AHR, adjusted HR; CT, Chlamydia trachomatis; GC, Neisseria gonorrhoeae; IDU, injection drug user; IQR, interquartile range; HAART, highly active antiretroviral therapy; HET, heterosexual transmission risk; MSM, men who have sex with men; ref, reference.